Mind + Muscle

technical minds + legal muscle


dig deep

FDA Approval Options for Follow-On Biologicals

  • 05.10.11
  • Paul A. Calvo & Timothy J. Shea, Jr.
  • World Intellectual Property Review

Parties seeking to market a follow-on biological product in the US traditionally have had two options for obtaining Food & Drug Administration approval of their product. With the passage of the Biologics Price Competition and Innovation Act last year, there is now a third option. Paul Calvo and Timothy Shea explain the key advantages and disadvantages of each.  Download the PDF for the full article.

Related People

Sort By Media Type

Sort By Media Type
  • AlertAlert
  • BriefsBriefs
  • Comments to USPTOComments to USPTO
  • Design Patent Case DigestDesign Patent Case Digest
  • MultimediaMultimedia
  • News & ArticlesNews & Articles
  • Press ReleasePress Release
  • VideoVideo
  • WebinarWebinar

Unsolicited e-mails and information sent to Sterne, Kessler, Goldstein & Fox P.L.L.C. will not be considered confidential or privileged, may be disclosed to others, may not receive a response, and do not create an attorney-client relationship with Sterne Kessler.  If you are not already a client of Sterne Kessler, do not include any confidential information in this message.